Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Co-Diagnostics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 35 | 33 | −2 |
| Shares | 5.15M | 5.62M | +466.9K (+9.1%) |
| Value | $1.44M | $1.93M | +$492.3K (+34.2%) |
New holders (3)
Institutions that held Co-Diagnostics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ground Swell Capital, LLC | 11,517 | $3.96K | 0.01% |
| Citadel Advisors LLC | 10,589 | $3.64K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,501 | $516 | 0.00% |
Sold out (5)
Institutions that held Co-Diagnostics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UMA Financial Services, Inc. | 28,375 | $7.95K |
| Rathbone Brothers plc | 25,000 | $7.00K |
| Triton Wealth Management, PLLC | 11,111 | $3.16K |
| Raymond James Financial Inc | 7,500 | $2.10K |
| CIBC Private Wealth Group, LLC | 1,000 | $280 |